Business Context and Reporting Period
Company: Commvault Systems, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: April 6, 2020
Date of Earliest Event: April 3, 2020
Context: The Board of Directors declared a dividend of one preferred share purchase right (a "Right") for each outstanding share of common stock. This action implements a poison pill defense mechanism designed to protect the Company and its stockholders from unsolicited takeover attempts and to ensure fair treatment for all stockholders.
Key Financial Metrics
This filing is a current report regarding a corporate governance action and does not contain financial performance data. The filing text does not provide values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes and Terms of the Rights Agreement
- Dividend Declaration: One Right per outstanding share of Common Stock, payable to stockholders of record on April 13, 2020.
- Exercise Price: $200.00 per one one-thousandth of a share of Series A Junior Participating Preferred Stock.
- Acquiring Person Threshold: The Rights are triggered if a person or group acquires beneficial ownership of 10% or more of the Common Stock (20% for passive institutional investors).
- Flip-In Trigger: If an Acquiring Person is identified, Rights holders (excluding the Acquiring Person) may purchase shares of Common Stock with a market value of two times the exercise price.
- Flip-Over Trigger: If the Company is acquired after an Acquiring Person is identified, Rights holders may purchase shares of the acquiring entity with a market value of two times the exercise price.
- Expiration: The Rights will expire on April 1, 2021, unless earlier redeemed or exchanged.
- Redemption: The Board may redeem the Rights in whole at $0.01 per Right at any time prior to the Distribution Date or Final Expiration Date.
Guidance, Outlook, and Risks
Management Commentary: The Board adopted the Rights Agreement to remain in the best position to perform its fiduciary duties and to enable all stockholders to realize the long-term value of their investment. The agreement is intended to discourage mergers, tender offers, or other business combinations not approved by the Board.
Risks and Contingencies:
- The Rights may cause substantial dilution to any person or group attempting to acquire the Company without Board approval.
- The overall effect may be to render more difficult or discourage a merger or tender offer.
- Until the Distribution Date, Rights transfer with the Common Stock and have no voting or dividend rights.
Important Facts for Investors to Verify
- Verify the Record Date of April 13, 2020, to determine eligibility for the Rights dividend.
- Confirm the specific definition of "Acquiring Person" (10% threshold) and how it applies to derivative positions.
- Review the full text of the Rights Agreement (Exhibit 4.1) for complete terms regarding adjustments and exceptions.
- Note that the Rights are not exercisable until the Distribution Date, which occurs upon the identification of an Acquiring Person or a Board determination.
- Understand that the Board retains the right to redeem the Rights at $0.01 per Right prior to triggering events.